November 12, 2025 18:30 ET | Source: FormFactor, Inc. FARMERS BRANCH, Texas and LIVERMORE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE)…
Offers AI-driven Solutions for Insurance Claims Management, and Insurance Product Delivery and Management MUMBAI, India and ISELIN, N.J. and LONDON, Nov. 11, 2025…
Leveraging HEG's global legacy, the company aims to build a cost-competitive and export-ready manufacturing base for the world's clean energy…
NEW DELHI, Oct. 29, 2025 /PRNewswire/ -- Trinasolar, a global leader in smart solar and energy storage solutions, is showcasing its…
In its sixth year, the annual research collaboration continues to examine the convergence of biodesign and biomimicry, advanced art and…
Hyundai Motor Group and Toray Group to develop advanced materials for future mobility, including high-performance vehicles and special-purpose mobilityHyundai Motor…
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and clear clinical proof of concept, including confirmed responses…
Latest release delivers native AI connectivity, behavioral analytics, and high-performance architecture for modern security operations INDIANAPOLIS and PARIS, Oct. 23,…
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression…